Navigation Links
Einstein to utilize electronic medical records system to analyze HIV/AIDS in central Africa
Date:9/8/2011

September 7, 2011 (BRONX, NY) In 2004, the global community acted in earnest to address the HIV/AIDS epidemic in Africa. As a result, millions of Africans are now receiving the same advanced antiretroviral therapy (ART) that has long been available in the developed world. While research shows that AIDS death rates in Africa have stabilized, little is known about the actual deployment and circumstances of treatment.

A consortium led by Albert Einstein College of Medicine of Yeshiva University has received a $4 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to spearhead the Central Africa International Epidemiologic Databases to Evaluate AIDS (CA-IeDEA). CA-IeDEA researchers will work directly with the governments of Burundi and Cameroon, as well as with non-governmental organizations in Rwanda, to collect and analyze the data of nearly 40,000 patients on ART.

The International Epidemiologic Databases to Evaluate AIDS (IeDEA) is a research consortium established in 2005 to address the unique and evolving questions in global HIV/AIDS research through regional and intra-regional observational data. Kathryn Anastos, M.D., co-director of Einstein's Global Health Center and co-principal investigator of the grant, and her team will be among the global team analyzing and publishing on the data produced. One of only seven IeDEA centers around the world, CA-IeDEA will create a robust and flexible database that will enable researchers to examine the real-world practice and results of ART including its impact on reducing cancer and interactions of HIV with other major, deadly diseases that afflict the region, such as malaria.

"Central Africa is a unique region that presents its own set of challenges for effective HIV/AID
'/>"/>

Contact: Kim Newman
sciencenews@einstein.yu.edu
718-430-3101
Albert Einstein College of Medicine
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Einstein scientists find crucial molecule involved in spread of breast cancer
2. Einstein secures $11 million to continue research on brain aging and Alzheimers disease
3. Einstein Montefiore lung specialist to receive award for work with 9/11 rescue workers
4. Feinstein scientists identify abnormal disease pathway in dystonia
5. Susan Band Horwitz, Ph.D., of Einstein, receives lifetime achievement award in cancer research
6. Einstein-Montefiore researcher will test nanoparticles against pancreatic cancer
7. ALBERT EINSTEIN COLLEGE OF MEDICINE HELPS ADDRESS NEED FOR IMPROVED CANCER CARE IN RURAL AMERICA
8. Feinstein Institute to share $5M US Department of Defense grant
9. Einstein scientist awarded $4 million to develop genetic strategy to combat tuberculosis
10. Einstein awarded NIH grant to study drug-resistant TB
11. NIH awards $10M to Einstein for diabetes research
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Einstein to utilize electronic medical records system to analyze HIV/AIDS in central Africa
(Date:7/30/2015)... ... 2015 , ... OncLive®’s extensive roster of Strategic ... Cancer Center (JCCC) mutually agreed to collaborate on projects that promote groundbreaking ... groups will help spread the news about the center’s leading-edge cancer research, robust ...
(Date:7/30/2015)... ... July 30, 2015 , ... Glidewell Laboratories, industry-leading provider of ... magazine, its multimedia publication focused on implant dentistry, is now available in print ... 6, Issue 2, as well as past issues of the dental laboratory’s quarterly ...
(Date:7/30/2015)... ... ... On July 23rd Clay Today Online reported the state of ... prison system, which has amassed largely enough throughout the years. Florida is the third ... Obama’s recent reduction of non violent drug offender’s prison sentences, Florida is beginning to ...
(Date:7/30/2015)... ... 30, 2015 , ... Gummy smile surgeon, Dr. Alex Farnoosh, now ... as well as the patented gum depigmentation treatmet. Dr. Farnoosh is a renowned dentist ... patients from around the world. , “Like treatment of any other disease or condition, ...
(Date:7/30/2015)... ... ... New research finds some distinct differences in the way mesothelioma behaves in younger ... website. , Researchers with the National Institutes of Health, the FDA, and the ... between 1990 and 2010. Two percent of these cases (207) occurred in people younger ...
Breaking Medicine News(10 mins):Health News:UCLA Jonsson Comprehensive Cancer Center Teams with OncLive® as a Strategic Alliance Partner 2Health News:UCLA Jonsson Comprehensive Cancer Center Teams with OncLive® as a Strategic Alliance Partner 3Health News:UCLA Jonsson Comprehensive Cancer Center Teams with OncLive® as a Strategic Alliance Partner 4Health News:Glidewell Laboratories Puts Out Latest Issue of Dental Implant Magazine Inclusive™ 2Health News:Glidewell Laboratories Puts Out Latest Issue of Dental Implant Magazine Inclusive™ 3Health News:Glidewell Laboratories Puts Out Latest Issue of Dental Implant Magazine Inclusive™ 4Health News:Florida Questions Its Spending on Punitive Incarceration in Light of Exorbitant Costs for Non Violent Offenders 2Health News:Florida Questions Its Spending on Punitive Incarceration in Light of Exorbitant Costs for Non Violent Offenders 3Health News:Gummy Smile Dentist, Alex Farnoosh DMD, is Now Offering Comprehensive Treatment Options for Gummy Smiles 2Health News:Study Finds Mesothelioma Behaves Differently in Younger People, According to Surviving Mesothelioma 2
... LEVERKUSEN, Germany and WEST HAVEN, Conn., Nov. 5 ... Drugs and,Medical Devices (BfArM), the U.S. Food and ... Bayer announced today that it,has elected to temporarily ... results from the Canadian BART trial can,be compiled, ...
... NATICK, Mass., Nov. 5 Boston Scientific,Corporation (NYSE: ... for the sale of its Cardiac Surgery and Vascular ... healthcare equipment,and systems. The transaction will be for a ... within the next 45-90 days, subject to regulatory,approvals and ...
... Funds But Many Fund,Trustees Say They Won,t Do Business With ... ... 5 More than five,hundred attendees at the International Foundation ... in the,opening hours of the convention on Sunday carrying bags ...
... TARRYTOWN, N.Y., Nov. 5 EpiCept Corporation,(Nasdaq: ... financial,results for the three and nine months ended September ... a net loss attributable to common,stockholders of $7.7 million, ... million, or $0.22 per basic and diluted share, for ...
... simplified treatment choices led to better outcomes, research ... Simplify. Simplify. Simplify. , New research shows this ... blood pressure, which is the leading risk factor ... to the future" approach to treating hypertension helped ...
... better when the dark delight is consumed, study suggests , ... A Japanese study finds that flavonoid-rich dark chocolate can improve ... as coronary flow velocity reserve (CFVR), an indicator of the ... blood flow in response to medications. , The two-week trial ...
Cached Medicine News:Health News:Bayer Temporarily Suspends Global Trasylol(R) Marketing 2Health News:Bayer Temporarily Suspends Global Trasylol(R) Marketing 3Health News:Bayer Temporarily Suspends Global Trasylol(R) Marketing 4Health News:Boston Scientific Announces Sale of Cardiac Surgery and Vascular Surgery Businesses 2Health News:Boston Scientific Announces Sale of Cardiac Surgery and Vascular Surgery Businesses 3Health News:Boston Scientific Announces Sale of Cardiac Surgery and Vascular Surgery Businesses 4Health News:Hundreds of Benefit Fund Trustees Question Viability of Rite Aid Pharmacy Benefit Management Company 2Health News:Hundreds of Benefit Fund Trustees Question Viability of Rite Aid Pharmacy Benefit Management Company 3Health News:Hundreds of Benefit Fund Trustees Question Viability of Rite Aid Pharmacy Benefit Management Company 4Health News:EpiCept Corporation Reports Third Quarter 2007 Operating and Financial Results 2Health News:EpiCept Corporation Reports Third Quarter 2007 Operating and Financial Results 3Health News:EpiCept Corporation Reports Third Quarter 2007 Operating and Financial Results 4Health News:EpiCept Corporation Reports Third Quarter 2007 Operating and Financial Results 5Health News:EpiCept Corporation Reports Third Quarter 2007 Operating and Financial Results 6Health News:EpiCept Corporation Reports Third Quarter 2007 Operating and Financial Results 7Health News:EpiCept Corporation Reports Third Quarter 2007 Operating and Financial Results 8Health News:EpiCept Corporation Reports Third Quarter 2007 Operating and Financial Results 9Health News:EpiCept Corporation Reports Third Quarter 2007 Operating and Financial Results 10Health News:New Measures Improve Heart Care 2Health News:New Measures Improve Heart Care 3Health News:New Measures Improve Heart Care 4Health News:Chocolate Has Sweet Effect on Blood Flow 2
(Date:7/30/2015)... , July 30, 2015  Arena Pharmaceuticals, Inc. (NASDAQ: ... conference call and webcast at 5:00 p.m. Eastern Time ... to discuss second quarter 2015 financial results and provide ... after the NASDAQ Global Select Market closes that day. ... dialing 877.643.7155 for domestic callers and 914.495.8552 for international ...
(Date:7/30/2015)... , July 30, 2015 EnteroMedics Inc. ... using neuroblocking technology to treat obesity, metabolic diseases and ... a conference call on Thursday, August 6, 2015, at ... the second quarter ended June 30, 2015, and to ... vBloc® Neurometabolic Therapy, delivered via the Maestro® System. ...
(Date:7/30/2015)... July 30, 2015 ... reports analyzing tumor biomarker tests, imaging, endoscopy ... for the global industry by technology and ... Industry (Tumor Biomarker Tests, Imaging, Endoscopy and ... talking about 9 companies and supported with ...
Breaking Medicine Technology:Arena Pharmaceuticals to Host Second Quarter 2015 Financial Results and Corporate Update Conference Call and Webcast on Wednesday, August 5 2Arena Pharmaceuticals to Host Second Quarter 2015 Financial Results and Corporate Update Conference Call and Webcast on Wednesday, August 5 3Arena Pharmaceuticals to Host Second Quarter 2015 Financial Results and Corporate Update Conference Call and Webcast on Wednesday, August 5 4EnteroMedics to Host Second Quarter 2015 Financial Results and Company Update Conference Call 2EnteroMedics to Host Second Quarter 2015 Financial Results and Company Update Conference Call 3Cancer Diagnostics Market to see 12% CAGR to 2020: Analysis of Tumor Biomarker Tests, Imaging, Endoscopy, Biopsy and More in New Research Reports 2Cancer Diagnostics Market to see 12% CAGR to 2020: Analysis of Tumor Biomarker Tests, Imaging, Endoscopy, Biopsy and More in New Research Reports 3Cancer Diagnostics Market to see 12% CAGR to 2020: Analysis of Tumor Biomarker Tests, Imaging, Endoscopy, Biopsy and More in New Research Reports 4Cancer Diagnostics Market to see 12% CAGR to 2020: Analysis of Tumor Biomarker Tests, Imaging, Endoscopy, Biopsy and More in New Research Reports 5Cancer Diagnostics Market to see 12% CAGR to 2020: Analysis of Tumor Biomarker Tests, Imaging, Endoscopy, Biopsy and More in New Research Reports 6
... Actavis, an international generic pharmaceutical company, today announced that ... a generic equivalent of Keppra XR®.  Shipping commenced immediately ... sales of approximately $161 million for the 12 months ... About Actavis: Actavis ...
... Germany, Sept. 15, 2011 Carl Zeiss Group ... improve global collaboration between employees, suppliers and subsidiaries around ... Carl Zeiss is a global leader in the optical ... companies in more than 30 countries Carl Zeiss ...
Cached Medicine Technology:Actavis Launches Generic Keppra XR® Tablets in the U.S. 2AT&T Helps Make The World a Smaller Place for Carl Zeiss 2AT&T Helps Make The World a Smaller Place for Carl Zeiss 3AT&T Helps Make The World a Smaller Place for Carl Zeiss 4
Representing the next step in the evolution of point-of-care testing, the i-STAT 1 Analyzer uses one platform to perform glucose strip testing along with all i-STAT test cartridges....
... The Attain 4194 Bipolar over-the-wire left-heart lead ... This new steroid-eluting lead has an angled ... a guidewire or a stylet delivery method, ... maneuver and position the lead in a ...
... lamp Reserve lamp at the flip of a ... a reserve lamp in primary port Thermostatically ... certification Lamp out indicator lets you know ... lamp for quick replacement. Mobile five-caster stand with ...
Mounted on a fully adjustable molded,headband with crown strap and comfort,cushions, the sturdy Trueview Classic is,lightweight, comfortable and durable....
Medicine Products: